Virology Research in South Africa—from a Great Legacy to an Optimistic Future

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "General Virology".

Deadline for manuscript submissions: 1 September 2024 | Viewed by 7381

Special Issue Editors


E-Mail Website
Guest Editor
Molecular Biology and Virology Research Laboratory, Department of Medical Biosciences, University of the Western Cape, Bellville 7535, South Africa
Interests: human coronaviruses; SARS-CoV; HCoV-NL63; MERS-CoV; SARS-CoV-2; molecular and cell biology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Virology, National Health Laboratory Service, Johannesburg, South Africa
2. Faculty of Health Sciences, Division of Medical Viriology, University of Cape Town, Cape Town, South Africa
Interests: molecular biology; viral phylogenetics; respiratory viruses; influenza; RSV; SARS-CoV-2; CMV; HIV
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We recently published a Viruses Special Issue entitled “State-of-the-Art Virology Research in South Africa”, which has garnered much interest and received numerous submissions. Given the success of the previous Special Issue, we are excited to extend an invitation to our colleagues to participate in a second volume of this Special Issue. The second volume of the Special Issue of the journal Viruses will focus on “Virology Research in South Africa—from a Great Legacy to an Optimistic Future”. As a continuation of the First Volume, this volume aims to provide a comprehensive overview of research on HIV, viral hepatitis, influenza, respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), coronaviruses, other less studied respiratory viruses, zoonotic viruses as well as research on viral vaccines, vaccine development and clinical trials on viral vaccines conducted in South Africa. Other areas relevant to this issue are research related to antiviral resistance for HIV and other viral drugs. This issue is not restricted to research on human viruses, and we invite submission of all virology research from South Africa. This is a great opportunity to showcase all the virus research, and new research niches, that were established due to the SARS-CoV-2 pandemic by South African researchers and their collaborators through submission of original research and review articles.

Prof. Dr. Burtram C. Fielding
Dr. Ziyaad Valley-Omar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • SARS-CoV-2
  • other respiratory viruses
  • vaccines
  • HIV
  • antiviral resistance
  • zoonotic viruses
  • hepatitis viruses
  • enteric viruses
  • novel viruses/virus discovery

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

18 pages, 951 KiB  
Article
Outbreaks of H5N1 High Pathogenicity Avian Influenza in South Africa in 2023 Were Caused by Two Distinct Sub-Genotypes of Clade 2.3.4.4b Viruses
by Celia Abolnik, Laura Christl Roberts, Christine Strydom, Albert Snyman and David Gordon Roberts
Viruses 2024, 16(6), 896; https://doi.org/10.3390/v16060896 (registering DOI) - 31 May 2024
Abstract
In 2023, South Africa continued to experience sporadic cases of clade 2.3.4.4b H5N1 high-pathogenicity avian influenza (HPAI) in coastal seabirds and poultry. Active environmental surveillance determined that H5Nx, H7Nx, H9Nx, H11Nx, H6N2, and H12N2, amongst other unidentified subtypes, circulated in wild birds and [...] Read more.
In 2023, South Africa continued to experience sporadic cases of clade 2.3.4.4b H5N1 high-pathogenicity avian influenza (HPAI) in coastal seabirds and poultry. Active environmental surveillance determined that H5Nx, H7Nx, H9Nx, H11Nx, H6N2, and H12N2, amongst other unidentified subtypes, circulated in wild birds and ostriches in 2023, but that H5Nx was predominant. Genome sequencing and phylogenetic analysis of confirmed H5N1 HPAI cases determined that only two of the fifteen sub-genotypes that circulated in South Africa in 2021–2022 still persisted in 2023. Sub-genotype SA13 remained restricted to coastal seabirds, with accelerated mutations observed in the neuraminidase protein. SA15 caused the chicken outbreaks, but outbreaks in the Paardeberg and George areas, in the Western Cape province, and the Camperdown region of the KwaZulu-Natal province were unrelated to each other, implicating wild birds as the source. All SA15 viruses contained a truncation in the PB1-F2 gene, but in the Western Cape SA15 chicken viruses, PA-X was putatively expressed as a novel isoform with eight additional amino acids. South African clade 2.3.4.4b H5N1 viruses had comparatively fewer markers of virulence and pathogenicity compared to European strains, a possible reason why no spillover to mammals has occurred here yet. Full article
9 pages, 1667 KiB  
Article
Exploring the Epidemiological Surveillance of Hepatitis A in South Africa: A 2023 Perspective
by Keveshan Bhagwandin, Jayendrie Thaver-Kleitman, Kathleen Subramoney, Morubula Jack Manamela and Nishi Prabdial-Sing
Viruses 2024, 16(6), 894; https://doi.org/10.3390/v16060894 (registering DOI) - 31 May 2024
Abstract
Hepatitis A (HAV) presents a significant global health concern with diverse clinical manifestations primarily transmitted through fecal–oral routes, emphasizing the critical role of sanitation and water cleanliness in transmission dynamics. Age-related variations, notably asymptomatic presentation in children, add complexity. The World Health Organization’s [...] Read more.
Hepatitis A (HAV) presents a significant global health concern with diverse clinical manifestations primarily transmitted through fecal–oral routes, emphasizing the critical role of sanitation and water cleanliness in transmission dynamics. Age-related variations, notably asymptomatic presentation in children, add complexity. The World Health Organization’s (WHO) endemicity classification aids in understanding prevalence and control strategies. This study examines 2023 South African epidemiological data on HAV cases, evaluating age distribution, incidence rates, and provincial disparities. Data from the national surveillance system and weather services were analyzed. Findings reveal distinct age-related trends, with the highest seroprevalence observed in the 5–9 age group with the most burdened areas located in the Western Cape, KwaZulu-Natal, and Gauteng provinces. Furthermore, seasonal rainfall variations correlate with increased incidence in Western Cape and KZN. The amalgamation of results suggest a potential epidemiological shift, emphasizing the need for updated immunization strategies. Noteworthy patterns, like the rise in 5–9-year-olds, may be influenced by factors such as school clustering and migration. Provincial disparities and the impact of climatic events underscore the necessity for dynamic vaccination strategies and surveillance network enhancements. This study highlights the urgency for improved understanding and response to HAV in South Africa. Full article
Show Figures

Figure 1

Other

Jump to: Research

20 pages, 2614 KiB  
Hypothesis
Herpesvirus Infection of Endothelial Cells as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by Jean M. Nunes, Douglas B. Kell and Etheresia Pretorius
Viruses 2024, 16(4), 572; https://doi.org/10.3390/v16040572 - 8 Apr 2024
Viewed by 7000
Abstract
Understanding the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is critical for advancing treatment options. This review explores the novel hypothesis that a herpesvirus infection of endothelial cells (ECs) may underlie ME/CFS symptomatology. We review evidence linking herpesviruses to persistent EC infection and [...] Read more.
Understanding the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is critical for advancing treatment options. This review explores the novel hypothesis that a herpesvirus infection of endothelial cells (ECs) may underlie ME/CFS symptomatology. We review evidence linking herpesviruses to persistent EC infection and the implications for endothelial dysfunction, encompassing blood flow regulation, coagulation, and cognitive impairment—symptoms consistent with ME/CFS and Long COVID. This paper provides a synthesis of current research on herpesvirus latency and reactivation, detailing the impact on ECs and subsequent systemic complications, including latent modulation and long-term maladaptation. We suggest that the chronicity of ME/CFS symptoms and the multisystemic nature of the disease may be partly attributable to herpesvirus-induced endothelial maladaptation. Our conclusions underscore the necessity for further investigation into the prevalence and load of herpesvirus infection within the ECs of ME/CFS patients. This review offers conceptual advances by proposing an endothelial infection model as a systemic mechanism contributing to ME/CFS, steering future research toward potentially unexplored avenues in understanding and treating this complex syndrome. Full article
Show Figures

Figure 1

Back to TopTop